Domiciliary noninvasive ventilatory support

Clinical Management of Chronic Obstructive Pulmonary Disease

Volumn , Issue , 2002, Pages 813-848

  Nava, Stefano ^a   Navalesi, Paolo ^b  

^a IRCCS   (Italy)

^b VALDUCE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 25844442429     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (143)

1. Thom TJ. International comparison in COPD mortality. Am Rev Respir Dis 1989; 140:S27–S34.
2. ATS. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77–S120.
3. Kircher T, Anderson RE. Cause of death: proper completion of the death certificate. JAMA 1987; 258:349–352.
4. Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156:814–818.
5. Sutherland JE, Persky VW, Brody JA. Proportionate mortality trends: 1950 through 1986. JAMA 1990; 264:3178–3184.
6. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV 1. The lung health study. JAMA 1994; 272:1497–1505.
7. Anthonisen NR, Wright EC, Hodgkin JE, and the IPPB Trial Group. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14–20.
8. Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, et al. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J 1997; 10:815–821.
9. Ulrik CS. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single-center randomized, double-blind, placebocontrolled, crossover study. Thorax 1995; 50:750–754.
10. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancent 1998; 351:773–780.
11. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic lung disease: a clinical trial. Ann Intern Med 1980; 93:391–398.
12. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis or emphysema. Lancet 1981; 1:681–686.
13. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351:24–27.
14. Make BJ and Fein AM. Is volume reduction surgery appropriate in the treatment of emphysema? No. Am J Respir Crit Care Med 1996; 153:1205–1207.
15. Fassler HE, Wise RA. Lung volume reduction surgery. Is less really more? Am J Respir Crit Care Med 1999; 159:1031–1035.
16. Meduri GU, Conoscenti CC, Menashe P, Nair S. Noninvasive face mask ventilation in patients with acute respiratory failure. Chest 1989; 95:865–870.
17. Garay SM, Turino GM, Goldring RM. Sustained reversal of chronic hypercapnia in patients with alveolar hypoventilation syndromes. Long-term maintenance with noninvasive nocturnal mechanical ventilation. Am J Med 1981; 70:269–274.
18. Sawicka EH, Loh L, Branthwaite MA. Domiciliary ventilatory support: an analysis of outcome. Thorax 1983; 43:31–35.
19. Strom K. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am Rev Respir Dis 1993; 147:585–591.
20. Miyamoto K, Aida A, Nishimura M, Aiba M, Kira S et al. Gender effect on prognosis of patients receiving long-term home oxygen therapy. Am J Respir Crit Care Med 1995; 152:972–976.
21. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive- Pressure Breathing Trial. Am Rev Respir Dis 1989; 139:1435–1438.
22. Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax 1987; 42: 105–110.
23. Vitacca M, Clini E, Porta R, Foglio K, Ambrosino N. Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation. Eur Respir J 1996; 9:1487–1493.
24. Dubois P, Jamart J, Machiels J, Smeets F, Lulling J. Prognosis of severely hypoxemic patients receiving long-term oxygen therapy. Chest 1994; 105:469–474.
25. Skwarski K, MacNee W, Wraith PK, Sliwinski P, Zielinski J. Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Chest 1991; 100:1522–1527.
26. Postma DS, Burema J, Gimeno F, May JF, Smit JM, et al. Prognosis in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1979; 119:357–367.
27. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2794–2800.
28. Begin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:905–912.
29. Bellemare F, Grassino A. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 1983; 55:8–15.
30. 2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 141:1194–1197.
31. Connors AF Jr., Dawson NV, Thomas C, Harrell FE Jr., Desbiens N, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154:959–967.
32. Costello R, Deegan P, Fitzpatrick M, McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with favorable prognosis. Am J Med 1997; 103:239–244.
33. Aida A, Miyamoto K, Nishimura M, Aiba M, Kira S, et al. Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy. Am J Respir Crit Care Med 1998; 158:188–193.
34. McNally E, Fitzpatrick M, Bourke S, Costello R, McNicholas WT. Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J 1993; 6:1353–1356.
35. Derenne JP, Fleury B, Pariente R. Acute respiratory failure of chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 138:1006–1033.
36. Sorli J, Grassino A, Lorange G, Milic-Emili J. Control of breathing in patients with chronic obstructive lung disease. Clin Sci Mol Med 1978; 54:295–304.
37. Aubier M, Murciano D, Milic-Emili J, et al. Effects of administration of O2 on ventilation and blood gases, in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 1980; 122:747–754.
38. Similowski T, Derenne JP. Relations entre hypercapnie et hypoxemie des insuffisants respiratories chroniques obstructifs (IRCO). Rev Mal Respir 1988; 5:373–380.
39. Douglas NJ. Sleep in patients with chronic obstructive pulmonary disease. Clin Chest Med 1998; 19(1):115–125.
40. Flenley DC, Millar JS. The effects of carbon dioxide inhalation on the inspiratory work of breathing in chronic respiratory failure. Clin Sci 1968; 34:385–395.
41. Servera E, Gimenez E. Clinical and functional evaluation of an incentive spirometer in patients with chronic obstructive pulmonary disease. Bull Eur Physiopathol Respir 1980; 16:265P.
42. Dolly FR, Block AJ. Medroxyprogesterone acetate in COPD: effect on breathing and oxygenation in sleeping and awake patients. Chest 1983; 84:394–398.
43. Brochard L, Isabey D, Piquet J, Amaro P, Mancebo J, et al. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. N Engl J Med 1990; 323:1523–1530.
44. Rochester DF, Bettini G. Diaphragmatic blood flow and energy expenditure in the dog: effects of inspiratory airflow resistance and hypercapnia. J Clin Invest 1976; 57: 661–672.
45. Kerby GR, Mayer LS, Pingleton SK. Nocturnal positive pressure ventilation via nasal mask. Am Rev Respir Dis 1987; 135:738–740.
46. Bach JR, Alba A, Mosher R, Delaubier A. Intermittent positive pressure ventilation via nasal access in the management of respiratory insufficiency. Chest 1987; 94:168–170.
47. Ellis ER, McCauley VB, Mellis C, Sullivan CE. Treatment of alveolar hypoventilation in a six year old girl with intermittent positive pressure ventilation through a nose mask. Am Rev Respir Dis 1987; 136:188–191.
48. Ellis ER, Grunstein RR, Chan S, Bye PT, Sullivan CE. Noninvasive respiratory support during sleep improves respiratory failure kyphoscoliosis. Chest 1988; 94:811–815.
49. Bach JR, Alba A. Management of chronic alveolar hypoventilation by nasal ventilation. Chest 1990; 97:52–57.
50. Leger P, Jennequin J, Gerard M, Robert D. Home positive pressure ventilation via nasal mask for patients with neuromuscular weakness or restrictive lung or chest wall deformities. Respir Care 1989; 34:73–77.
51. Waldhorn RE. Nocturnal nasal intermittent positive pressure ventilation with bi-level positive airway pressure (BiPAP) in respiratory failure. Chest 1992; 101:516–521.
52. Heckmatt JZ, Loh L, Dubowitz V. Night-time nasal ventilation in neuromuscular disease. Lancet 1990; 335:579–582.
53. Goldstein RS, De Rosie JA, Avendano MA, Dolmage TE. Influence of noninvasive positive pressure ventilation on inspiratory muscles. Chest 1991; 99:408–415.
54. Bellemare F, Grassino A. Effect of pressure and timing of contraction on human diaphragm fatigue. J Appl Physiol 1982; 53:1190–1195.
55. Nava S, Zanotti E, Ambrosino N, Scarabelli C, Fracchia C, Rampulla C. Evidence of acute diaphragmatic fatigue in natural condition: the diaphragm during labour. Am Rev Respir Dis 1992; 146:1226–1230.
56. Vassilakopoulos T, Zakynthinos S, Roussos C. The tension-time index and the frequency/tidal volume ratio are the major pathophysiologic determinants of weaning failure and success. Am J Respir Crit Care Med 1998; 158:378–385.
57. NHLBI workshop summary. Respiratory muscle fatigue. Am Rev Respir Dis 1990; 142:474–480.
58. Ambrosino N, Nava S, Bertone P, Fracchia C, Rampulla C. Physiologic evaluation of pressure support ventilation by nasal mask in patients with stable COPD. Chest 1992; 101:385–391.
59. Rodenstein DO, Stanescu DC, Cutitta G, Liistro G, Veritier C. Ventilatory and diaphragmatic EMG responses to negative-pressure ventilation in airflow obstruction. J Appl Physiol 1988; 65:1621–1626.
60. Nava S, Ambrosino N, Zocchi L, Rampulla C. Diaphragmatic rest during negative pressure ventilation by pneumowrap. Assessment in normal and COPD patients. Chest 1990; 98:857–865.
61. Belman MJ, Soo Hoo G, Kuei JH, Shadmehr R. Efficacy of positive vs negative pressure ventilation in unloading the respiratory muscles. Chest 1990; 98:850–856.
62. Meechan-Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med 1995; 152:538–544.
63. Gutierrez M, Beroiza T, Contreras G, Diaz O, Cruz E, Moreno R, Lisboa C. Weekly cuirass ventilation improves blood gases and inspiratory muscle strength in patients with chronic air-flow limitation and hypercapnia. Am Rev Respir Dis 1988; 138:617–623.
64. Strumpf DA, Millman RP, Carlisle CC, Grattan LM, Ryan SM, Erickson AD, Hill NS. Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 144:1234–1239.
65. Celli B, Lee H, Criner G, Bermudez M, Rassullo J, Gilmartin M, Miller G, Make B. Controlled trial of external negative pressure ventilation in patients with severe chronic airflow obstruction. Am Rev Respir Dis 1989; 140:1251–1256.
66. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991; 325:917–923.
67. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997; 337:1799–1806.
68. Bergofsky E. Respiratory failure in disorders of the thoracic cage. Am Rev Respir Dis 1979; 119:643–669.
69. White KF, Drinnan MJ, Smithson AJ, et al. Respiratory muscle activity during rapid eye movement (REM) sleep in patients with chronic obstructive pulmonary disease. Thorax 1995; 50:376–382.
70. Becker HF, Piper AJ, Flynn WE, McNamara SG, Grunstein RR, et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 1999; 159: 112–118.
71. Annane D, Quera-Salva MA, Lofaso F, Vercken JB, Lesiur O, et al. Mechanics underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular disease. Eur Respir J 1999; 13:157–162.
72. Roussos C. Function and fatigue of respiratory muscles. Chest 1985; 88(suppl 2): 124S–132S.
73. 2 during recovery from severe asthma. Clin Sci 1971; 41:13–21.
74. Elliott MW, Mulvey DA, Moxham J, Green M, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tension. Eur Respir J 1991; 4:1044–1052.
75. Elliott MW, Simonds AK, Carroll MP, Wedzicha JA, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in hypercapnic respiratory failure due to chronic obstructive lung disease: effects on sleep and quality of life. Thorax 1992; 47:342–348.
76. Lin CC. Comparison between nocturnal nasal positive pressure ventilation combined with oxygen therapy and oxygen monotherapy in patients with severe COPD. Am J Respir Crit Care Med 1996; 154:353–358.
77. Simonds AK, Parker RA, Branthwaite MA. The effect of intermittent positive-pressure hyperinflation in restrictive chest wall disease. Respiration 1989; 55:136–143.
78. Estenne M, Gevenois PA, Kinnear W, Soudon P, Helporn A, et al. Lung volume restriction in patients with chronic respiratory muscle weakness: the role of microatelectasis. Thorax 1993; 48:698–701.
79. Nava S, Navalesi P. Long-term nasal pressure support ventilation in stable COPD patients: Is it worth it? Am J Respir Crit Care Med. 1998; 157(3): A224.
80. Diaz O, Iglesia R, Ferrer M, Zavala E, Santos C, et al. Effects of noninvasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156:1840–1845.
81. Schonhofer B, Wenzel M, Barchfeld T, Kohler D. Nocturnal mechanical ventilation decreases pulmonary hypertension in chronic respiratory failure. Eur Respir J 1997; 10:A0333.
82. Emery CJ, Sloan PJ, Mohammed FH, Barer GR. The action of hypercapnia during hypoxia on pulmonary vessels. Bull Eur Physiopathol Respir 1977; 13:763–776.
83. Meyer TJ, Hill NS. Noninvasive positive pressure ventilation to treat respiratory failure. Ann Intern Med 1994; 120:760–770.
84. Carroll N, Branthwaite MA. Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation. Thorax 1988; 43:349–353.
85. Marino W. Intermittent volume cycled mechanical ventilation via nasal mask in patients with respiratory failure due to COPD. Chest 1991; 99:681–684.
86. Leger P, Bedicam JM, Cornette A, Reybet-Degat O, Langevin B, et al. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest 1994; 105:100–105.
87. Renston JP, DiMarco AF, Supinski GS. Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe COPD. Chest 1994; 105:1053–1060.
88. Perrin C, El Far Y, Vandenbos F, Tamisier R, Dumon MC, et al. Domiciliary nasal intermittent positive pressure ventilation in severe COPD: effects on lung function and quality of life. Eur Respir J 1997; 10:2835–2839.
89. Sivasothy P, Smith IE, Shneerson JM. Mask intermittent positive pressure ventilation in chronic hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Eur Respir J 1998; 11:34–40.
90. Jones SE, Packham S, Hebden M, Smith AP. Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: longterm follow up and effect on survival. Thorax 1998; 53:495–498.
91. Gay PC, Hubmayr RD, Stroetz RW. Efficacy of nocturnal nasal ventilation in stable, severe chronic obstructive pulmonary disease during a 3-month controlled trial. Mayo Clin Proc 1996; 71:533–542.
92. Nava S, Ambrosino N, Rubini F, Fracchia C, Torri G, et al. Effect of nasal pressure support ventilation and external PEEP on diaphragmatic function in severe stable COPD patients. Chest 1993; 103:143–150.
93. Muir JF, Cuvelier A, Tenang B and the European task force on mechanical ventilation and COPD. Long-term home nasal intermittent positive pressure ventilation (NIPPV) + oxygenotherapy (LTOT) versus LTOT alone in severe hypercapnic COPD. Preliminary results of a European multicentre trial. Am J Respir Crit Care Med 1997; 155:A408.
94. Clini E, Sturani C on behalf of AIPO. The Italian multicenter study of noninvasive pressure support ventilation in COPD patients. Am J Respir Crit Care Med 1999; 159: A295.
95. Cropp A, DiMarco AF. Effects of intermittent negative pressure ventilation on respiratory muscle function in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1987; 135:1056–1061.
96. Zibrak JD, Hill NS, Federman EC, Kwa SL, O’Donnell C. Evaluation of intermittent long-term negative-pressure ventilation in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 138:1515–1518.
97. Ambrosino N, Montagna T, Nava S, Negri A, Fracchia C, Brega S, Rampulla C. Short term effect of intermittent negative pressure ventilation in COPD patients with respiratory failure. Eur Respir J 1990; 3:502–508.
98. Shapiro SH, Ernst P, Gray-Donald K, Martin JC, Wood-Dauphinee S, et al. Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease. Lancet 1992; 340:1425–1429.
99. Gigliotti F, Spinelli A, Duranti R, Gorini M, Goti P, et al. Four-week negative pressure ventilation improves respiratory function in severe hypercapnic COPD patients. Chest 1994; 105:87–94.
100. Della Torre M, Rubini F, Confalonieri M, Nava S. Predictors of success for non-invasive mechanical ventilation in chronic respiratory failure. Am J Respir Crit Care Med 1998; 157:A226.
101. Nava S, Evangelisti I, Rampulla C, Compagnoni ML, Fracchia C, et al. Human and financial costs of non-invasive mechanical ventilation in patients affected by chronic obstructive pulmonary disease and acute respiratory failure. Chest 1997; 111:1631–1638.
102. Chevrolet JC, Jolliet P, Abajo B, Toussi A, Louis M. Nasal positive pressure ventilation in patients with acute respiratory failure. Difficult and time-consuming procedure for nurses. Chest 1991; 100:775–782.
103. Hill NS, Eveloff SE, Carlisle CC, Goff SG. Efficacy of nocturnal nasal ventilation in patients with restrictive thoracic disease. Am Rev Respir Dis 1992; 145:365–371.
104. MacIntyre NR, Ho LI. Effect of initial flow rate and breath termination criteria on pressure support ventilation. Chest 1991; 99:134–138.
105. Nava S, Bruschi C, Rubini F, Palo A, Iotti G, et al. Respiratory response and inspiratory effort during pressure support ventilation in COPD patients. Intensive Care Med 1995; 21:871–879.
106. Vitacca M, Rubini F, Foglio K, Scalvini S, Nava S, et al. Non-invasive modalities of positive pressure ventilation improve the outcome of acute exacerbation in COLD patients. Intensive Care Med 1991; 19:450–455.
107. Meechan-Jones DJ, Paul EA, Grahame-Clarke C, Wedzicha JA. Nasal ventilation in acute exacerbations of chronic obstructive pulmonary disease: effect of ventilator mode on arterial blood gas tensions. Thorax 1994; 49:1222–1224.
108. Girault C, Richard JC, Chevron V, Tamion F, Pasquis P, et al. Comparative physiologic effects of noninvasive assist-control and pressure support ventilation in acute hypercapnic respiratory failure. Chest 1997; 11:1639–1648.
109. Meechan-Jones DJ, Wedzicha JA. Comparison of pressure and volume preset nasal ventilator systems in stable chronic respiratory failure. Eur Respir J 1993; 6:1060–1064.
110. Navalesi P, Fanfulla F, Frigerio P, Gregoretti C, Nava S. Physiologic evaluation of noninvasive mechanical ventilation delivered with three types of mask in patients with chronic hypercapnic respiratory failure. Crit Care Med, In press.
111. Schonhofer B, Sonnebron M, Haidl P, Bohrer H, Kohler D. Comparison of two different modes for noninvasive mechanical ventilation in chronic respiratory failure: volume versus pressure controlled device. Eur Respir J 1997; 10:184–191.
112. Parreira VF, Delguste P, Jounieaux V, Aubert G, Dury M. Effectiveness of controlled and spontaneous modes in nasal two-level positive pressure ventilation in awake and asleep normal subjects. Chest 1997; 112:1267–1277.
113. Bunburaphong T, Imanaka H, Nishimura M, Hess D, Kacmarek RM. Performance characteristics of bilevel pressure ventilators: a lung model study. Chest 1997; 111: 1050–1060.
114. Nava S, Ambrosino N, Confalonieri M, et al. Physiologic effects of flow and pressure triggering during non-invasive mechanical ventilation in patients affected by chronic obstructive pulmonary disease. Thorax 1997; 52:249–254.
115. Bomarchand G, Chevron V, Chopin C, Jusserand D, Girault C, et al. Increased initial flow rate reduces inspiratory work of breathing during pressure support ventilation in patients with exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 1996; 22:1147–1154.
116. Elliott M, Moxham J. Noninvasive mechanical ventilation by nasal or face mask. In: Martin Tobin, ed. Principles and Practice of Mechanical Ventilation. New York: McGraw-Hill, 1994:427–453.
117. Nava S, Bruschi C, Fracchia C, Braschi A, Rubini F. Patient-ventilator interaction and inspiratory effort during pressure support ventilation in patients with different pathologies. Eur Respir J 1997; 10:177–183.
118. Zanotti E, Rubini F, Iotti G, Bruschi C, Palo A, et al. Elevated static compliance of the total respiratory system: early predictor of weaning unsuccess in severe COPD patients mechanically ventilated. Intensive Care Med 1995; 2:399–405.
119. Broseghini C, Brandolese R, Poggi R, Polese G, Manzin E, et al. Respiratory mechanics during the first day of mechanical ventilation in patients with pulmonary edema and chronic airway obstruction. Am Rev Respir Dis 1988; 138:355–361.
120. Mancebo J, Benito S, Martin M, Net A. Value of static pulmonary compliance in predicting mortality in patients with acute respiratory failure. Intensive Care Med 1988; 14:110–114.
121. Nava S, Rubini F. Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis. Thorax 1999; 54:390–395.
122. Kacmarek RM, Hess D. Equipment required for home mechanical ventilation. In: Martin Tobin, ed. Principles and Practice of Mechanical Ventilation. New York: McGraw- Hill, 1994:111–154.
123. Appendini L, Patessio A, Zanaboni S, Carone M, Gukov B, et al. Physiologic effect of positive end-expiratory pressure and mask pressure support during exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149:1069–1076.
124. Kress JP, O’Connor MF, Schmidt GA. Clinical examination reliability detects intrinsic positive end-expiratory pressure in critically ill, mechanically ventilated patients. Am J Respir Crit Care Med 1999; 159:290–294.
125. Delguste P, Aubert-Tulkens G, Rodenstein DO. Upper airway obstruction during nasal intermittent positive-pressure hyperventilation in sleep. Lancet 1991; 338:1295–1297.
126. Marrone O, Stallone A, Salvaggio A, Milone F, Bellia V, Bonsignore G. Occurrence of breathing disorders during CPAP administration in obstructive sleep apnea. Eur Respir J 1991; 4:660–666.
127. Schonhofer B, Geibel M, Sonneborn M, Haidl P, Kohler D. Daytime mechanical ventilation in chronic respiratory insufficiency. Eur Respir J 1997; 10:2840–2846.
128. Tsuboi T, Ohi M, Kita H, Otsuka N, Hirata H, et al. The efficacy of a custom-fabricated nasal mask on gas exchange during nasal intermittent positive pressure ventilation. Eur Respir J 1999; 13:152–156.
129. Carrey Z, Gottfried SB, Levy RD. Ventilatory muscle support in respiratory failure with nasal positive pressure ventilation. Chest 1990; 97:150–158.
130. Lofaso F, Aslanian P, Richard JC, Isabey D, Hang T, et al. Expiratory valves used for home devices: experimental and clinical comparison. Eur Respir J 1998; 11:1382–1388.
131. Lofaso F, Brochard L, Touchard D, Hang T, Harf A, et al. Evaluation of carbon dioxide rebreathing during pressure support ventilation with airway management system (BiPAP) devices. Chest 1995; 108:772–778.
132. 2 rebreathing during BiPAP ventilatory assistance. Am J Respir Crit Care Med 1995; 151:1126–1135.
133. Draft Reviewer Guidance for Ventilators, Anesthesiology, Respiratory, and Defibrillator Devices Group. Division of Cardiovascular, Respiratory and Neurological Devices, July 1995.
134. Celli B. Home mechanical ventilation. In: Martin Tobin, ed. Principles and Practice of Mechanical Ventilation. New York: McGraw-Hill, 1994:619–630.
135. Gilmartin ME. Long-term mechanical ventilation outside the hospital. In: DJ Pierson, RM Kacmarek, eds. Respiratory Care. New-York: Churchill Livingstone, 1992:1185–1204.
136. Plummer AL, O’Donohue WJ Jr., Petty TL. Consensus conference on problems in home mechanical ventilation. Am Rev Respir Dis 1989; 140:555–560.
137. Takayagi Y, Proctor DF, Salman S, Evering S. Effects of cold air and carbon dioxide on nasal air flow resistance. Ann Otol Rhinol Laryngol 1969; 78:40–48.
138. Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF, et al. Nasal challenge with cold, dry air results in release of inflammatory mediators: possible mast cell involvement. J Clin Invest 1985; 76:1375–1381.
139. Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sullivan CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154:182–186.
140. Goularte TA, Craven DE. Results of a survey of infection control practices for respiratory therapy equipment. Infect Control Hosp Epidemiol 1986; 7:327–330.
141. Craven DE, Connolly MC, Lichtenberg DA, Primeau PJ, McCabe WR. Contamination of mechanical ventilators with tubings changes every 24 or 48 hours. N Engl J Med 1982; 306:1505–1509.
142. Muir JF, Voisin C, Ludot A. Organization of home respiratory care: the experience in France with ANTADIR. Monaldi Arch Chest Dis 1993; 48:462–467.
143. Meduri GU, Turner RE, Abou-Shala N, Wunderink R, Tolley E. Noninvasive positive pressure ventilation via face mask: first-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure. Chest 1996; 109:179–193.